Skip to content
Open access

Binding of voriconazole aptamers and modulation of binding by cyclodextrins

Aug 2026 · Nanotechnology · Vol 37 · 0 citations · 30 references
Physics Medicine

TL;DR

ThT fluorescence is a useful label-free method to study voriconazole aptamers and that aptamers can be used to probe target binding to nanoscale host molecules and that aptamers can be used to probe target binding to nanoscale host molecules.

Abstract

Voriconazole is a broad-spectrum antifungal drug widely used to treat life-threatening fungal infections, including invasive aspergillosis and severe candidiasis. Despite its efficacy, large inter- and intra-patient pharmacokinetic variability and frequent drug–drug interactions can lead to subtherapeutic or toxic plasma concentrations, making therapeutic drug monitoring essential. Recently, several aptamer selections for voriconazole have been reported, including two independent selections from our laboratory that yielded multiple aptamer families. In this work, we systematically characterize these aptamers by measuring their binding affinities under various conditions using thioflavin T (ThT) fluorescence spectroscopy and evaluating their selectivity against structurally related antifungal drugs. A new aptamer named VO3 with a dissociation constant (KD) value of 26 μM and high selectivity was identified. The effect of the buffer components such as NaCl and MgCl2 was assessed, and VO3 maintained binding activity even in up to 1 M NaCl and in the absence of Mg2+ ions. Furthermore, the interaction of α- and β- cyclodextrins with voriconazole was studied using a competitive titration method, and only β-cyclodextrin could compete with the aptamer for binding to voriconazole. This study shows that ThT fluorescence is a useful label-free method to study voriconazole aptamers and that aptamers can be used to probe target binding to nanoscale host molecules.

Read PDF

Similar papers

Review Jul 2026

Long-Acting Lipoglycopeptide Treatment of Invasive Gram-Positive Infections

A narrative review, including the pharmacological characteristics of dalbavancin (DAL) and oritavancin (ORI), the only currently available laLGPs, as well as their approved and “off-label” use reported in the literature to date.

Madison E. Salam, D. Chastain, Douglas N. Fish et al. · 0 citations
Open access Jul 2026

Complexation of teicoplanin and sulfobutylether-β-cyclodextrin: experimental and theoretical insights into the potential relevance of their molecular interaction to teicoplanin pharmacokinetics.

The results collectively indicate that the direct molecular interaction, whereby the hydrophobic cavity of SBE-β-CD encapsulates most of the hydrophobic side chain of TEIC, can reduce TEIC protein binding and may consequently affect its pharmacokinetics.

Y. Yamada, S. Nakagawa, N. Yoshikawa et al. · 0 citations
Open access Aug 2026

Computational Discovery of Novel CYP51 Inhibitors for Antifungal Therapy Against Aspergillus fumigatus.

Findings identify Boeravinone D, Nimbidin, and 7-acetyl neotrichilenone as promising CYP51 inhibitors and all three candidates showed favorable ADMET profiles, although 7-acetyl neotrichilenone may require optimization to improve solubility.

S. Mohammad, Taqdees Fatima Shahid, Sana Noor et al. · 0 citations
Aug 2026

Novel salicylamido sulfonamides as CD73 immune checkpoint inhibitors: Synthesis and in vitro biological evaluation.

In silico ADME analysis indicated that both lead compounds possess favourable drug-like properties, with no Lipinski's rule-of-five violations, balanced lipophilicity, and acceptable predicted oral absorption, supporting their pharmacokinetic potential.

Dinesh Krishna Narukulla, Shrilekha Chilvery, C. Godugu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.